ELEXACAFTOR
Elexacaftor is a CFTR modulator improving chloride transport in cystic fibrosis, commonly combined in triple therapy. Side effects include elevated liver enzymes, rash, and abdominal pain.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Elexacaftor is a CFTR corrector that improves folding, trafficking and stability of mutated CFTR proteins, especially F508del variants. It increases the quantity of functional CFTR at the cell surface and is used in combination regimens to enhance chloride transport. Its mechanism involves stabilization of NBD1–MSD interfaces in the CFTR structure.
Benefits and Advantages
Used in CFTR‑corrector research, epithelial‑ion‑transport modelling, cystic‑fibrosis combination‑therapy studies, and protein‑folding pathway assays.
Side Effects and Risks
Risks include hepatic enzyme elevations, rash, respiratory symptoms and drug‑interaction concerns. Handle with CFTR‑modulator precautions.
Datasheet
| Molecular Formula | C26H34F3N7O4S |
|---|---|
| Molecular Weight | 597.7 g/mol |
| CAS Number | 2216712-66-0 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | <1mg/mL |
| Purity | Purity information is available upon request (COA). |
| Synonym | Elexacaftor; 2216712-66-0; VX-445; RRN67GMB0V; 3-Pyridinecarboxamide, N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-((4S)-2,2,4-trimethyl-1-pyrrolidinyl)- |
| IUPAC/Chemical Name | N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide |
| InChl Key | MVRHVFSOIWFBTE-INIZCTEOSA-N |
| InChl Code | InChI=1S/C26H34F3N7O4S/c1-16-12-25(5,6)35(13-16)22-18(23(37)33-41(38,39)19-14-34(7)31-17(19)2)8-9-20(30-22)36-11-10-21(32-36)40-15-24(3,4)26(27,28)29/h8-11,14,16H,12-13,15H2,1-7H3,(H,33,37)/t16-/m0/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

